Cyclophosphamide in vitiligo
Gokhale, B.B.; Parakh, A.P.
Indian Journal of Dermatology 28(1): 7-10
1983
ISSN/ISBN: 0019-5154 PMID: 6852882 Document Number: 206137
Document emailed within 1 workday
Related Documents
Trouillas, P.; Neuschwander, P.; Nighoghossian, N.; Adeleine, P.; Tremisi, P. 1989: Intensive immunosuppression in progressive multiple sclerosis. An open study comparing 3 groups: cyclophosphamide, cyclophosphamide-plasmapheresis and control subjects. Results after 3 years Revue Neurologique (Paris) 145(5): 369-377West, R.J.; Zweig, S.F. 1997: Meta-analysis of chemotherapy regimens for ovarian carcinoma: a reassessment of cisplatin, cyclophosphamide and doxorubicin versus cisplatin and cyclophosphamide European Journal of Gynaecological Oncology 18(5): 343-348
Jardine, I.; Fenselau, C.; Appler, M.; Kan, M.N.; Brundrett, R.B.; Colvin, M. 1978: Quantitation by gas chromatography-chemical ionization mass spectrometry of cyclophosphamide, phosphoramide mustard, and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapy Cancer Research 38(2): 408-415
Taguchi, T.; Sakai, K.; Terasawa, T.; Wada, H. 1986: Results of clinical trials with a CMitF (cyclophosphamide, mitoxantrone, and 5-fluorouracil) regimen versus a CAF (cyclophosphamide, adriamycin, and 5-fluorouracil) regimen in advanced/relapsed breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(9): 2820-2828
Hainsworth, J.D.; Wolff, S.N.; Stein, R.S.; Greer, J.P.; Cousar, J.B.; Greco, F.A. 1986: Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis Cancer Treatment Reports 70(8): 953-958
Bezwoda, W.R.; Rastogi, R.B. 1994: A randomized comparative study of cyclophosphamide, vincristine, doxorubicin, and prednisolone and cyclophosphamide, vincristine, mitoxantrone, and prednisolone regimens in the treatment of intermediate- and high-grade lymphoma with 8 years' follow-up Seminars in Hematology 31(2 Suppl 3: 3
Uzuka, Y.; Saito, Y.; Takahashi, H.; Komatsu, M.; Ito, T. 1989: Combination chemotherapy of multiple myeloma--BCNU.cyclophosphamide.procarbazine.prednisolone and MCNU.cyclophosphamide.procarbazine.prednisolone therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(6): 2269-2273
Studnitsin, A.A. 1979: Vitiligo Fel'dsher i Akusherka 44(4): 60-61
Alhaidari, Z. 2000: Cat vitiligo Annales de Dermatologie et de Venereologie 127(4): 413
Fisher, A.A. 1976: Vitiligo due to contactants Cutis 17(3): 431-437; 438
Sharma, L.; Bhawan, R.; Jain, R.K. 2004: Hypoacusis in vitiligo Indian Journal of Dermatology Venereology and Leprology 70(3): 162-164
Lassus, A.; Apajalahti, A.; Blomqvist, K.; Mustakallio, M.; Kiistala, U. 1972: Vitiligo and neoplasms Acta Dermato-Venereologica 52(3): 229-232
Herbst, R.A. 2007: New treatments for vitiligo? Medizinische Monatsschrift für Pharmazeuten 30(10): 379-380
Brostoff, H.; Brostoff, J. 1978: Vitiligo and steroids Lancet 2(8091): 688
Verma, K.C.; Jain, V.K. 1981: Dermatoglyphics in Vitiligo Indian Journal of Dermatology Venereology and Leprology 47(2): 102-104
Thurmon, T.F.; Jackson, J.; Fowler, C.G. 1976: Deafness and vitiligo Birth Defects Original Article Series 12(5): 315-320
Arroyo, M.P.; Tift, L. 2003: Vitiligo therapy: where are we now? Journal of Drugs in Dermatology: Jdd 2(4): 404-408
Borisenko, K.K. 1973: Pathogenesis and treatment of vitiligo Vestnik Dermatologii i Venerologii 47(5): 11-16
Kumar, S.; Singh, A.; Prasad, R.R. 2011: Role of histopathology in vitiligo Journal of the Indian Medical Association 109(9): 657-658; 665
Koshevenko, I.N. 1984: Clinical characteristics of vitiligo Vestnik Dermatologii i Venerologii 3: 60-63